Skip to content

Comparison of the three drug combination succinylcholine and thiopental "with" propofol and fentanyl "or" intravenous midazolam and fentanyl "success and complication reduction in shoulder

The comparison of the success and complications in shoulders reduction with using three drug combination succinylcholine and thiopental "with" propofol and fentanyl "with" midazolam and fentanyl in Imam Hussein hospital of Tehran.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017032323559N10
Enrollment
150
Registered
2017-04-24
Start date
2017-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reduction of shoulders. Dislocation of shoulder joint

Interventions

Intervention 1: The first group: consists of succinylcholine 20 mg and thiopental with 5.3 mg/kg dose(drugs prescription to titrated and slow injection). Intervention 2: The Second group: consists of
Treatment - Drugs
The first group: consists of succinylcholine 20 mg and thiopental with 5.3 mg/kg dose(drugs prescription to titrated and slow injection)
The Second group: consists of propofol with 1-3 mg/kg doses and Fentanyl with 2-3 mg/kg dose(drugs prescription to titrated and slow injection)
The third group: includes a midazolam with 3-5 mg dose and fentanyl with 2-3 mg/kg dose(drugs prescription to titrated and slow injection)

Sponsors

Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients 18 to 65 years old with anterior or posterior shoulder dislocation; Admitted to the emergency; consent to participate in the study. Exclusion criteria: physical condition above III based on the ASA; patients with major fracture dislocation; other major injuries; history of drug abuse; patients with poisoning.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Reduction success. Timepoint: Up to 5 minutes after reduction. Method of measurement: Checked by X-ray.;Reduction complications. Timepoint: Until clearance. Method of measurement: Through examination of patient.

Secondary

MeasureTime frame
Pain score. Timepoint: During reduction. Method of measurement: Based on VAS score.;Sedation score. Timepoint: During reduction. Method of measurement: Ramsey sedation score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid kariman MD

shahid Beheshti University of Medical Sciences

h.kariman49@gmail.com+98 21 7755 8001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026